Trifarma Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLINDAMYCIN PHOSPHATE USP, with a corresponding US DMF Number 12922.
Remarkably, this DMF maintains an Active status since its submission on April 02, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 06, 2014, and payment made on February 26, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II